Clinical Trials List
2018-05-01 - 2023-05-17
Phase III
Not yet recruiting6
Terminated1
ICD-10A49.9
Bacterial infection, unspecified
-
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/15
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chung-Hao Huang Division of Infectious Disease
- Shang-Yi Lin Division of Infectious Disease
- 張雅婷 Division of Infectious Disease
- Chau-Chyun Sheu Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Fu-Lun Chen Division of Infectious Disease
- Yu-Tien Tzeng Division of Infectious Disease
- Shian-Jiun Lin Division of Infectious Disease
- Tsong-Yih Ou 未分科
- Wen-Sen Lee Division of Infectious Disease
- Han-Lin Hsu Division of Infectious Disease
- Chih-Hsin Lee Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Audit
None
Co-Principal Investigator
- 陳瑞光 Division of General Internal Medicine
- 周稚偵 Division of General Internal Medicine
- 張博閔 Division of General Internal Medicine
- 吳冠陞 Division of General Internal Medicine
- 陳以書 Division of General Internal Medicine
- 蔡忠育 Division of General Internal Medicine
- 陳垚生 Division of General Internal Medicine
- 曾鈺婷 Division of General Internal Medicine
- 王國強 Division of General Internal Medicine
- 施正蓮 Division of General Internal Medicine
- 梁宗榮 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jann-Tay Wang Division of General Internal Medicine
- 莊祐中 Division of General Internal Medicine
- Chung-Yu Chen 未分科
- - - Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Study Contacts
- -
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
426 participants
